Bunge Global SA has been in the limelight for various reasons. Notably, the company's third-quarter profit and earnings per share were on the downside, yet it outperformed market estimates. Alterations on key stake-holders were recorded with State of Alaska Department of Revenue selling 8,470 shares and
abrdn plc buying 11,808.
Forsta AP Fonden also increased its position in Bunge. Amid these changes, attention centered on Bunge's $8.2B
Viterra deal, which has faced delays and attracted European antitrust scrutiny. Yet, signals suggest the acquisition is nearing, with Bunge initiating offers for
Viterra notes. However, completion isn't expected until 2025. On the corporate side, Bunge Limited Finance Corp extended and commenced exchange offers and consent solicitations. The company also sold its ownership share in
BP Bunge Bioenergia joint venture and announced intentions to develop oilseeds for renewables with
Biotech Moolec. Bunge’s stock hit dip at $86.05, but analysts suggest future upside. In addition, Bunge announced a pricing of $2.0 billion senior notes offering and planned to change its incorporation country from Bermuda to Switzerland, which has been completed.
Bunge Global Sa BG News Analytics from Thu, 08 Dec 2022 08:00:00 GMT to Sat, 02 Nov 2024 08:42:19 GMT -
Rating 3
- Innovation 0
- Information 6
- Rumor -3
